Project Concepts (Strategic Research Agreements) supports investigators pursuing type 1 diabetes research to address critical gaps and advance breakthroughs that could prevent, treat, or cure the disease.
Funder: Breakthrough T1D
Due Dates: November 5, 2026 (Round 1 LOI) | December 17, 2026 (Round 1 notification) | May 6, 2027 (Round 2 LOI) | June 17, 2027 (Round 2 notification)
Funding Amounts: Annual budget and award duration as approved per application
Summary: Supports research concepts aligned with Breakthrough T1D’s current Research Strategy through Strategic Research Agreements.
Key Information: Applicants need a qualifying doctoral degree and faculty-level position or equivalent; full proposals require LOI approval.
Project Concepts is Breakthrough T1D’s semi-annual opportunity to submit Strategic Research Agreement Letters of Intent (LOIs) addressing its current Research Strategy. The mechanism supports investigators working on critical gaps and challenges in type 1 diabetes research, with priority given to concepts offering transformative breakthroughs to prevent, treat, or cure the disease. Breakthrough T1D encourages innovative, high-risk/high-reward, field-changing research.
Strategic Research Agreements are partnerships between investigators and Breakthrough T1D scientists, involving cooperative research-plan development and interaction before and during the award. The mechanism encompasses single-project, multi-project, and clinical research. Clinical agreements support therapeutic trials and non-interventional patient-oriented studies intended to develop clinical interventions or monitoring tools for diabetes and its complications.